Meeder Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-251
Closed -$53K 2408
2020
Q2
$53K Buy
251
+223
+796% +$45.9K ﹤0.01% 911
2020
Q1
$5K Sell
28
-167
-86% -$39.3K ﹤0.01% 1818
2019
Q4
$47K Buy
195
+174
+829% +$33.5K ﹤0.01% 1035
2019
Q3
$4K Sell
21
-91
-81% -$20.6K ﹤0.01% 1840
2019
Q2
$22K Buy
+112
New +$24.2K ﹤0.01% 1210

Other funds holding TECX

Meeder Asset Management's TECX Position: Q3 2020 in Review

Meeder Asset Management sold out of Tectonic Therapeutic (TECX) in Q3 2020, closing a stake of 251 shares — an estimated $53K sold.

Meeder Asset Management first reported a position in TECX in Q2 2019 and held it in 5 quarters. The position peaked at $53K in Q2 2020. 101 funds tracked by Wall St. Rank hold TECX as of Q3 2020.

  • Meeder Asset Management reported no remaining Tectonic Therapeutic position as of Q3 2020 after selling out during the quarter.
  • Meeder Asset Management sold 251 Tectonic Therapeutic shares in Q3 2020, an estimated $53K.
  • Meeder Asset Management first reported a position in Tectonic Therapeutic in Q2 2019 and held it in 5 quarters.
  • Meeder Asset Management's Tectonic Therapeutic position peaked at $53K in Q2 2020.
  • 101 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q3 2020.

Based on Meeder Asset Management's 13F filing for Q3 2020, filed 2 Nov 2020.